Nuclear Medicine Market

TABLE OF CONTENTS

1. Introduction
   • Definition of Nuclear Medicine Market / Radiopharmaceuticals Market
   • Scope of the Report
2. Methodology
   • Executive Summary
   • Market Overview
   • Market Definition and Segmentation
3. Market Dynamics
   • Drivers
   • Restraints
   • Opportunities
   • Porter's Five Forces Analysis
   • PESTEL Analysis
4. Nuclear Medicine Market / Radiopharmaceuticals Market, By Type:
   • Diagnostic Nuclear Medicine
     • SPECT Radiopharmaceuticals
       • Tc-99m
       • I-123
       • Tl-201
       • Ga-67
       • Other SPECT Isotopes
     • PET Radiopharmaceuticals
       • F-18
       • Rb-82
       • Other PET Isotopes
   • Therapeutic Nuclear Medicine
     • Alpha Emitters
       • Ra-223
     • Beta Emitters
       • I-131
       • Y-90
       • Sm-153
       • Lu-177
       • Re-186
       • Other Beta Emitters
   • Brachytherapy Isotopes
     • I-125
     • Ir-192
     • Pd-103
     • Cs-131
     • Other Brachytherapy Isotopes
5. Nuclear Medicine Market / Radiopharmaceuticals Market, By Applications:
   • Diagnostic Applications
     • SPECT Applications
       • Cardiology
       • Bone Scans
       • Thyroid Applications
       • Pulmonary Scans
       • Other SPECT Applications
     • PET Applications
       • Oncology
       • Cardiology
       • Neurology
       • Other PET Applications
     • Therapeutic Applications
       • Thyroid Indications
       • Bone Metastasis
       • Lymphoma
       • Endocrine Tumors
       • Other Indications
6. Nuclear Medicine Market / Radiopharmaceuticals Market, By Procedural Volume Assessment:
   • Diagnostic Procedures
     • SPECT Procedures
     • PET Procedures
   • Therapeutic Procedures
7. Nuclear Medicine Market / Radiopharmaceuticals Market, By End User:
   • Hospitals
   • Imaging Centers
   • Academic & Research Centers
   • Other end users
8. Nuclear Medicine Market / Radiopharmaceuticals Market, By Geography
   • North America
     • United States
     • Canada
   • Europe
     • United Kingdom
     • Germany
     • France
     • Spain
     • Italy
     • Rest of Europe
   • Asia-Pacific
     • China
     • Japan
     • India
     • South Korea
     • Australia
     • Rest of Asia-Pacific
   • Latin America
     • Brazil
     • Mexico
     • Rest of Latin America
   • Middle East & Africa
     • Saudi Arabia
     • United Arab Emirates
     • South Africa
     • Rest of Middle East & Africa
9. Competitive Landscape
10. Company Profiles
    • Cyclopharm
      • Company Overview
      • Product Portfolio and Description
      • Key Highlights
      • Financial Overview
    • YantaiDongcheng Pharmaceutical Group Co., Ltd.
    • Bayer AG
    • Bracco Imaging S.P.A.
    • Nordion Inc.
    • Siemens Healthineers
    • Isotopia Molecular Imaging Ltd.
    • Lantheus Holdings, Inc.
    • Eckert & Ziegler
    • China Isotope & Radiation Corporation
    • Northstar Medical Radioisotopes
    • Eczacibasi-Monrol Nuclear Products
    • Curium
    • IRE ELIT
    • Shine Technologies, Llc
    • Isotope JSC
    • Institute Of Isotopes
    • Global Medical Solutions
    • NTP Radioisotopes SOC Ltd. (A Subsidiary Of South African Nuclear Energy Corporation)
    • Cardinal Health
    • BWXT Medical Ltd.
    • Jubilant Draximage, Inc. (A Subsidiary Of Jubilant Pharma)
    • Advanced Accelerator Applications (A Novartis Company)
    • Pharmalogic Holdings Corp.
    • GE Healthcare
11. Conclusion and Future Outlook
12. Appendix
    • Research Methodology
    • About the Pharmanucleus

13. Disclaimer